Richard M. Ransohoff is Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine, as well as Staff Scientist in the Dept. of Neurosciences of the Lerner Research Institute and Staff Neurologist in the Mellen Center for MS Treatment and Research, both at the Cleveland Clinic Foundation (CCF), Cleveland, OH. Dr. Ransohoff graduated with honors from Bard College, Annandale, NY, with a B.A. in Literature and received the M.D. degree with honors from Case School of Medicine, Cleveland, OH. He completed residencies in Internal Medicine (Mt. Sinai Medical Center, Cleveland, OH; Board Certified 1981) and Neurology (CCF; Board Certified 1985). From 1984 until 1989, Dr. Ransohoff was a post-doctoral fellow in the laboratory of Dr. Timothy Nilsen, Dept. of Molecular Biology and Microbiology, Case School of Medicine.
Among other honors and awards, he received a Physician's Research Training Award from the American Cancer Society (1984-86); a Harry Weaver Neuroscience Scholarship from the National Multiple Sclerosis Society (NMSS; 1987-1992); a Clinical Investigator Development Award from the National Institutes of Health (NIH; 1988-1993); and the John and Samuel Bard Award in Science and Medicine, 2002. He has been cited from 1996 through 2004 in the "Best Doctors in America" for his expertise in the clinical care of patients with multiple sclerosis (MS).
Dr. Ransohoff served as regular member on NIH and NMSS Study Sections and on numerous Special Emphasis Panels, and has served as Chair of the NMSS Peer Review Committee B starting in October, 2004. He is a member of the Editorial Boards of the Journal of Immunology, (where he is presently Section Editor); Trends in Immunology; and the Journal of Neuroimmunology. From 1998-2000, Dr. Ransohoff was a member of the NINDS Director's Planning Panel on "The Neural Environment." He is a member of the Steering Committee for the NIH Therapeutic Development Program in Spinal Muscular Atrophy; the International Advisory Boards for the 7th (2004) and 8th (2006) Congresses on Neuroimmunology; and the Scientific Advisory Board for Chemocentryx, San Carlos, CA. He serves on External Advisory Boards for CHARTER (CNS HIV Anti-Retroviral Therapy Effects Research; MH22005); a Program Project on Alexander's Disease (NS 42803); the MS Lesion Project (NMSS RG 3185); the University of Nebraska's Center for Neurovirology & Neurodegenerative Disorders (NS43985) and is the External Advisor for the European Union's Project on "Mechanisms of Brain Inflammation" (QLG3-00612). He is a member of the National MS Society's Medical Advisory Board. He is a Co-director of the Marine Biological Laboratory's special topics course on "Pathogenesis of neuroimmunological disease," held biennially at Wood's Hole, MA.
For the past decade, Dr. Ransohoff's research has focused on the functions of chemokines and chemokine receptors in development and pathology of the nervous system. He also has a longstanding and continuing interest in the mechanisms of action of interferon-beta. Dr. Ransohoff has received continuous research support from the NIH and the NMSS since 1988. He has published more than 130 scientific reports, more than 35 reviews and book chapters, and three edited books.
Dr. Ransohoff is a member of the American Academy of Neurology, the American Neurological Association, the American Association for the Advancement of Science and the American Association of Immunologists.